168 related articles for article (PubMed ID: 31626886)
21. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
[TBL] [Abstract][Full Text] [Related]
22. Risk of second primary malignancies in patients with cutaneous melanoma.
Schmid-Wendtner MH; Baumert J; Wendtner CM; Plewig G; Volkenandt M
Br J Dermatol; 2001 Dec; 145(6):981-5. PubMed ID: 11899153
[TBL] [Abstract][Full Text] [Related]
23. Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma: A SEER-Based Analysis.
Eid E; Maloney NJ; Cai ZR; Zaba LC; Kibbi N; John EM; Linos E
JAMA Dermatol; 2023 Nov; 159(11):1248-1252. PubMed ID: 37703005
[TBL] [Abstract][Full Text] [Related]
24. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study.
Frisch M; Hjalgrim H; Olsen JH; Melbye M
Ann Intern Med; 1996 Nov; 125(10):815-21. PubMed ID: 8928988
[TBL] [Abstract][Full Text] [Related]
25. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma.
Schenk M; Severson RK; Pawlish KS
Cancer; 1998 May; 82(9):1672-6. PubMed ID: 9576287
[TBL] [Abstract][Full Text] [Related]
26. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
Goggins WB; Finkelstein DM; Tsao H
Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
[TBL] [Abstract][Full Text] [Related]
27. Second primary malignancies in patients with non-melanoma skin cancer: Results from a cancer registry-based study in Emilia Romagna, north-east Italy.
Borghi A; Corazza M; Chiaranda G; Michiara M; Mangone L; Caruso B; Falcini F; Maestri I; Ferretti S
Cancer Epidemiol; 2019 Aug; 61():176-184. PubMed ID: 31301588
[TBL] [Abstract][Full Text] [Related]
28. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
29. Increased risk of second primary cancers after a diagnosis of melanoma.
Bradford PT; Freedman DM; Goldstein AM; Tucker MA
Arch Dermatol; 2010 Mar; 146(3):265-72. PubMed ID: 20231496
[TBL] [Abstract][Full Text] [Related]
30. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.
Goggins WB; Tsao H
Cancer; 2003 Feb; 97(3):639-43. PubMed ID: 12548605
[TBL] [Abstract][Full Text] [Related]
31. Relationship of uveal and cutaneous malignant melanoma in persons with multiple primary tumors.
Shors AR; Iwamoto S; Doody DR; Weiss NS
Int J Cancer; 2002 Nov; 102(3):266-8. PubMed ID: 12397648
[TBL] [Abstract][Full Text] [Related]
32. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract][Full Text] [Related]
33. Risk of second primary cancer in men with breast cancer.
Satram-Hoang S; Ziogas A; Anton-Culver H
Breast Cancer Res; 2007; 9(1):R10. PubMed ID: 17254323
[TBL] [Abstract][Full Text] [Related]
34. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
[TBL] [Abstract][Full Text] [Related]
35. Subsequent primary cancers after basal-cell carcinoma: A nationwide study in Finland from 1953 to 1995.
Milán T; Pukkala E; Verkasalo PK; Kaprio J; Jansén CT; Koskenvuo M; Teppo L
Int J Cancer; 2000 Jul; 87(2):283-8. PubMed ID: 10861488
[TBL] [Abstract][Full Text] [Related]
36. Incidence of New Primary Cutaneous Melanoma in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors: A Single-Center Cohort Study.
Nanda JK; Dusza SW; Navarrete-Dechent C; Liopyris K; Marghoob AA; Marchetti MA
JAMA Dermatol; 2021 Jan; 157(1):79-83. PubMed ID: 32936222
[TBL] [Abstract][Full Text] [Related]
37. Risk for second primary cancers among pediatric and young adult melanoma survivors.
Luu Y; Han J; Agarwal A; Elkady N; Jaroonwanichkul S; Gulati N; Gittler J
Pediatr Dermatol; 2024; 41(1):12-15. PubMed ID: 37776000
[TBL] [Abstract][Full Text] [Related]
38. Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study.
Helgadottir H; Isaksson K; Fritz I; Ingvar C; Lapins J; Höiom V; Newton-Bishop J; Olsson H
J Natl Cancer Inst; 2021 Mar; 113(3):318-328. PubMed ID: 32577730
[TBL] [Abstract][Full Text] [Related]
39. Second primary tumors in patients with cutaneous malignant melanoma.
Bhatia S; Estrada-Batres L; Maryon T; Bogue M; Chu D
Cancer; 1999 Nov; 86(10):2014-20. PubMed ID: 10570426
[TBL] [Abstract][Full Text] [Related]
40. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
Moore MM; Geller AC; Warton EM; Schwalbe J; Asgari MM
J Am Acad Dermatol; 2015 Oct; 73(4):630-6. PubMed ID: 26298295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
